BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,488 Cr | ₹6,231 Cr | ₹3,573 Cr | ₹2,058 Cr | ₹1,517 Cr |
What is the latest Sundry Debtors ratio of BIOCON ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹5,488 Cr |
| Mar2024 | ₹6,231 Cr |
| Mar2023 | ₹3,573 Cr |
| Mar2022 | ₹2,058 Cr |
| Mar2021 | ₹1,517 Cr |
How is Sundry Debtors of BIOCON Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,488 Cr | -11.92 | |
| Mar2024 | ₹6,231 Cr | 74.37 | |
| Mar2023 | ₹3,573 Cr | 73.61 | |
| Mar2022 | ₹2,058 Cr | 35.66 | |
| Mar2021 | ₹1,517 Cr | - | |
Compare Sundry Debtors of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹50,826.1 Cr | 2.1% | 10.9% | 20.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 2.1% |
10.9% |
20.3% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses